Turk HM - Search Results

1

The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.

Ak G, Buyukberber S, Sevinc A, Turk HM, Ates M, Sari R, Savli H, Cigli A. Ak G, et al. Among authors: turk hm. J Diabetes Complications. 2001 May-Jun;15(3):150-7. doi: 10.1016/s1056-8727(01)00137-4. J Diabetes Complications. 2001. PMID: 11358684

2

Elevated serum CA-125 levels in patients with nephrotic syndrome-induced ascites.

Sevinc A, Buyukberber S, Sari R, Turk HM, Ates M. Sevinc A, et al. Among authors: turk hm. Anticancer Res. 2000 Mar-Apr;20(2B):1201-3. Anticancer Res. 2000. PMID: 10810422

3

Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes.

Turk HM, Buyukberber S, Sevinc A, Ak G, Ates M, Sari R, Savli H, Cigli A. Turk HM, et al. Diabetes Care. 2000 Jun;23(6):864-7. doi: 10.2337/diacare.23.6.864a. Diabetes Care. 2000. PMID: 10841017 No abstract available.

4

Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus.

Turk HM, Sevinc A, Camci C, Cigli A, Buyukberber S, Savli H, Bayraktar N. Turk HM, et al. Acta Diabetol. 2002 Sep;39(3):117-22. doi: 10.1007/s005920200029. Acta Diabetol. 2002. PMID: 12357295

5

Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids.

Sevinc A, Buyukberber S, Sari R, Kiroglu Y, Turk HM, Ates M. Sevinc A, et al. Among authors: turk hm. Gynecol Oncol. 2000 May;77(2):254-7. doi: 10.1006/gyno.2000.5776. Gynecol Oncol. 2000. PMID: 10785474

6

Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid.

Turk HM, Pekdemir H, Buyukberber S, Sevinc A, Camci C, Kocabas R, Tarakcioglu M, Buyukberber NM. Turk HM, et al. Tumour Biol. 2003 Aug-Sep;24(4):172-5. doi: 10.1159/000074425. Tumour Biol. 2003. PMID: 14654710

7

How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma.

Sevinc A, Camci C, Turk HM, Buyukberber S. Sevinc A, et al. Among authors: turk hm. Oncology. 2003;65(1):1-6. doi: 10.1159/000071198. Oncology. 2003. PMID: 12837976 Review.

8

The prevalence of hepatitis G virus in cancer patients.

Büyükberber N, Büyükberber S, Kadayifci A, Guney C, Camci C, Balkan A, Kubar A, Turk HM, Sevinc A. Büyükberber N, et al. Among authors: turk hm. New Microbiol. 2003 Jul;26(3):243-8. New Microbiol. 2003. PMID: 12901419

9

Adrenomedullin expression does not correlate with survival in lung cancer.

Buyukberber S, Sari I, Camci C, Buyukberber NM, Sevinc A, Turk HM. Buyukberber S, et al. Among authors: turk hm. Med Oncol. 2007;24(2):245-9. doi: 10.1007/BF02698047. Med Oncol. 2007. PMID: 17848751

10

Markers of bone turnover in patients with lung cancer.

Dane F, Turk HM, Sevinc A, Buyukberber S, Camci C, Tarakcioglu M. Dane F, et al. Among authors: turk hm. J Natl Med Assoc. 2008 Apr;100(4):425-8. doi: 10.1016/s0027-9684(15)31276-1. J Natl Med Assoc. 2008. PMID: 18481482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters